References
- Pan D, Sze S, Minhas JS, et al. The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. EClinicalMedicine. 2020;23:100404.
- Polack FP, Thomas SJ, Kitchin N, C4591001 Clinical Trial Group, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
- Mallapaty S. Vaccines are curbing COVID: data from Israel show drop in infections. Nature. 2021;590(7845):197.
- Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring – United States, December 14, 2020–January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(8):283–288.
- Bae S, Lee YW, Lim SY, et al. Adverse reactions following the first dose of ChAdOx1 nCoV-19 vaccine and BNT162b2 vaccine for healthcare workers in South Korea. J Korean Med Sci. 2021;36(17):e115.
- Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2102.
- Verma AK, Lavine KJ, Lin CY. Myocarditis after Covid-19 mRNA vaccination. N Engl J Med. 2021;NEJMc:2109975.
- Rosee PL, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477.
- Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
- Trottestam H, Horne A, Arico M, for the Histiocyte Society, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. blood. 2011;118(17):4577–4584.
- Janka GE, Lehmber K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013;2013:605–611.
- Noor R. Developmental status of the potential vaccines for the mitigation of the COVID-19 pandemic and a focus on the effectiveness of the Pfizer-BioNTech and Moderna mRNA vaccines. Curr Clin Microbiol Rep. 2021;3:1–8.
- Ehl S, Astigarraga I, Greenwood T, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH steering committee of the histiocyte society. J Allergy Clin Immunol Pract. 2018;6(5):1508–1517.
- Keshavarz P, Yazdanpanah F, Rafiee F, et al. Lymphadenopathy following COVID-19 vaccination: imaging findings review. Acad Radiol. 2021;28(8):1058–1071.
- Skawran S, Gennari AG, Dittli M, et al. 18F]FDG uptake of axillary LNs after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact. Eur Radiol. 2021;22:1–9.